Statisticians in Pharmaceutical Industry. Hans Ulrich Burger SSG, October 18, 2013

Size: px
Start display at page:

Download "Statisticians in Pharmaceutical Industry. Hans Ulrich Burger SSG, October 18, 2013"

Transcription

1 Statisticians in Pharmaceutical Industry Hans Ulrich Burger SSG, October 18,

2 Objectives History of biostatisticians in pharmaceutical industry Important roles and tasks in drug development Opportunities for statisticians in pharmaceutical industry Career opportunities Pharmaceutical industry: A changing environment 2

3 History of biostatisticians in pharmaceutical industry Started in the 70 s 70 s and 80 s: Statisticians to a large extent employed as consultants To calculate sample sizes for studies and write related sections in the protocol No impact on analysis and trial interpretation 90 s: Take on reporting safety and efficacy Start to become integrated in development teams Last decade: Becoming more strategic Move from a statistician working in drug development to a drug developer with biostatistics background 3

4 History of biostatisticians in pharmaceutical industry Drug development today organized globally Many sites Many therapeutic areas to work on Biostatistics usually part of a larger organization frequently called biometrics Data management and statistical programming separate Biostatistics works in a metric structure on development teams together with Pharmacology and medical Scientist Operations Regulatory Research Business and production 4

5 Important roles and tasks in drug development Planning Designing drug development plans Protocol writing Strategy discussions Reporting Programming and analysis Interpretation and CSR writing Others: HA interactions and registration Drug safety Biomarker Experimental studies 5

6 Important roles and tasks in drug development Important roles Statisticians on individual studies (usually larger phase III trials) Project lead statistician for an early program Project lead statistician for a late program Technical specialists Therapeutic area leads Important is Not to be seen as a support function only but as an integral part of drug development To be seen as a strategic player 6

7 Important roles and tasks in drug development Three core competencies Statistical knowledge Key principles to control confounding factors Statistical procedures and competence to apply Good understanding of variability Drug development experience Personal competence Integrity, passion and courage Communication Ability to speak the language of our costumers Willing to speak up with confidence Networking 7

8 Further opportunities in pharmaceutical industry Non-clinical statistics Quality assurance in pharma technical (production) Marketing Pricing and health economics Marketing trials Epidemiology Disease pattern and population definition Analysis of observational studies Portfolio management 8

9 Opportunities in pharmaceutical industry (II) Note: Scientific backbone of clinical studies and other experimental settings frequently of statistical nature: This concerns as well Understanding of key principles Interpretation of data and underlying variability Statisticians needed! Word of caution: These opportunities are primarily for pharma. CROs as by today may offer different opportunities Note: Methodology is important but not necessarily in the foreground 9

10 Really important: Data interpretation 10

11 Biostatistics activities Clinical development Level 1 deliverables: Documents and analyses Level 2 deliverables: Strategic Input in Methodological excellence Input and standards for Strategic excellence Input and standards for - Protocol writing including sample size determination - DAP writing - Output control and QA - Adhoc programming - SRS and report writing - HA response analyses and writing - Analysis of pre-clinical experiments -Protocol design - Design of development program - Data interpretation - Regulatory strategy - Program conclusions - Defining key features of pre-clinical experiments - Result interpretation of pre-clinical experiments -Defining optimal analyses - Stat. Procedures - Defining optimal designs - Special methods - Adaptive designs - Bayesian designs -Protocol design - Analysis strategies - Program development strategies - Portfolio strategies - Biomarker analyses - PTS and portfolio decision making - Risk benefit strategies 11

12 Example: Career paths (Roche) Cross functional path Technical path Team lead Management path initiatives LCTL GH DSTL Senior technical expert TAGH Site head Team leader for cross functional strategies Project team lead (SH) BR Technical expert PLS Team leader for technical teams Team leader for SOP/processes teams Deputy GH FLM BSTL Deputy PLS ED lead Study Statistician 12

13 Career opportunities in clinical development Career opportunities usually within statistics There are impressive careers starting in statistics and then ending in leadership roles outside statistics Important is a decent motivation and the willingness to work independently and take on ownership An entrepreneurial mindset to go into new areas for statistics may be specifically important Career opportunities are not only in management. Leadership roles are not only in management Most important for statisticians in future probably are strategic leadership! 13

14 Changing environment Today: Business model for whole pharma industry put in question Raising cost pressure Good CRO infrastructure Increasingly good infrastructure in low cost countries Outsourcing models starting everywhere to CROs with better cost structure Other sites with better cost structure Increased pressure why we would need statisticians at main, expensive sites Development more advanced and more critical for clinical data management and programming due to smaller strategic abilities 14

15 Changing environment How should statisticians react? Diversification: Think about where statisticians could be needed Strategic component: Think about how we can show best value to an organization Participate in driving the strategy for a study, for a whole project and for the company 15

16 Changing environment In todays pharmaceutical industry statisticians who just like operational work may not have job security Statisticians have to become largely strategic Methodology Strategy What does this mean for the education Focus not only on methodology and how to do things Focus on why we do things and what are the key principles Do nothing without having understood why we need to do it! Challenge continuously current practice 16

17 Most important: Strategic impact 17

18 Thank you! 18

Future roles and opportunities for statisticians in pharmaceutical industry

Future roles and opportunities for statisticians in pharmaceutical industry Future roles and opportunities for statisticians in pharmaceutical industry H. Ulrich Burger 1), Stefan Driessen 2), Chrissie Fletcher 3), Michael Branson 4), Christoph Gerlinger 5) 1) Hoffmann-La Roche

More information

BioWorld s PARTNER in FOCUS: Covance AN ADVERTISING SERVICE FROM BIOWORLD

BioWorld s PARTNER in FOCUS: Covance AN ADVERTISING SERVICE FROM BIOWORLD BioWorld s PARTNER in FOCUS: Covance AN ADVERTISING SERVICE FROM BIOWORLD PARTNERING Trend Allows Smart CROs TO Provide Gamut of Services TO Any Size COMPANy Five years ago, contract research organizations

More information

Careers in Biostatistics and Clinical SAS Programming An Overview for the Uninitiated Justina M. Flavin, Independent Consultant, San Diego, CA

Careers in Biostatistics and Clinical SAS Programming An Overview for the Uninitiated Justina M. Flavin, Independent Consultant, San Diego, CA PharmaSUG 2014 Paper CP07 Careers in Biostatistics and Clinical SAS Programming An Overview for the Uninitiated Justina M. Flavin, Independent Consultant, San Diego, CA ABSTRACT In the biopharmaceutical

More information

Quality by Design Concept

Quality by Design Concept 3rd Jerusalem Conference on Quality and Pharma Sciences 6-7 June, 2012 QbD in Clinical Research - Where Can QbD Impact Clinical Research Practices? Dr. Yafit Stark Vice President, TEVA Pharmaceutical Industries,

More information

Development of CDISC Tuberculosis Data Standards

Development of CDISC Tuberculosis Data Standards Development of CDISC Tuberculosis Data Standards Michael Fiola Senior Director / Quintiles The presenters have disclosed that they have no proprietary or financial interests in the topics covered in this

More information

Effective Outsourcing of Clinical Pharmacology Studies in Europe. John Horkulak Executive Director, Eurasian External Clinical Study Operations

Effective Outsourcing of Clinical Pharmacology Studies in Europe. John Horkulak Executive Director, Eurasian External Clinical Study Operations Effective Outsourcing of Clinical Pharmacology Studies in Europe John Horkulak Executive Director, Eurasian External Clinical Study Operations Key Questions Do clinical pharmacology studies require a different

More information

Overview. Health Science Authority. Implementation of ICH guideline in Singapore. Singapore s experience

Overview. Health Science Authority. Implementation of ICH guideline in Singapore. Singapore s experience ICH and Singapore Dr Christina Lim Deputy Group Director, Health Product Regulation Group Senior Advisor, International Collaboration Health Sciences Authority Singapore November 2008 Overview Health Science

More information

PharmaSUG 2013 - Paper IB05

PharmaSUG 2013 - Paper IB05 PharmaSUG 2013 - Paper IB05 The Value of an Advanced Degree in Statistics as a Clinical Statistical SAS Programmer Mark Matthews, inventiv Health Clinical, Indianapolis, IN Ying (Evelyn) Guo, PAREXEL International,

More information

Meeting Priorities of Biotech & Small Pharma Companies

Meeting Priorities of Biotech & Small Pharma Companies Meeting Priorities of Biotech & Small Pharma Companies Dr. Andreas Orfanos, MBBCH,FFPM,MBA Thrasos Therapeutics Inc. Vice President Clinical Research & Development 28 Oct 2015 Montreal Technoparc Private,

More information

Course Certificate In. Pharmaceuticals and Medical Research: Clinical Research Monitoring & Coordination

Course Certificate In. Pharmaceuticals and Medical Research: Clinical Research Monitoring & Coordination Course Certificate In Pharmaceuticals and Medical Research: Clinical Research Monitoring & Coordination Welcome to the latest in distance learning courses designed to prepare you, on your own schedule,

More information

Key considerations for outsourcing late phase clinical research

Key considerations for outsourcing late phase clinical research Key considerations for outsourcing late phase clinical research Alan Nelson (on behalf of Van Zyl Engelbrecht) Senior Project Director at UBC: An Express Script Company Layout of presentation My presentation

More information

Lilly Covance Strategic Alliance From Vision to Results. Adrienne Takacs, PhD Jonathan Koch, MBA

Lilly Covance Strategic Alliance From Vision to Results. Adrienne Takacs, PhD Jonathan Koch, MBA Lilly Covance Strategic Alliance From Vision to Results Adrienne Takacs, PhD Jonathan Koch, MBA Topics 1. Lilly s Challenge... a Partnership Opportunity 2. Our Landmark Agreement 3. A Local Success Story

More information

THE BIOTECH & PHARMACEUTICAL INDUSTRY

THE BIOTECH & PHARMACEUTICAL INDUSTRY THE BIOTECH & PHARMACEUTICAL INDUSTRY ESSENTIAL CAREERS INFORMATION CALUM LECKIE KATIE BISARO CAREERS CONSULTANTS What we will cover Sector overview Types of role Graduate recruitment trends and issues

More information

Clinical Data Management. Medical Writing. Bio-Statistics & Programming

Clinical Data Management. Medical Writing. Bio-Statistics & Programming Clinical Data Management Medical Writing Bio-Statistics & Programming About Us Clinnex is a Quality focused ICH/GCP compliant Clinical Research Organization (CRO) with focus on providing high quality Biometrics

More information

Masters Learning mode (Форма обучения)

Masters Learning mode (Форма обучения) Program Title (Название программы): Pharmacology Degree (Степень) Masters Learning mode (Форма обучения) Full-time and part-time Duration of study (Продолжительность программы) 2 years (4 years part time)

More information

Needs, Providing Solutions

Needs, Providing Solutions Identifying Needs, Providing Solutions 1 I n d u s t r y The growth of medical research and the countless innovations coming from the pharmaceutical, biotechnology and medical device industry, has improved

More information

Strategies to Prepare for Meetings with the FDA. Kim Colangelo Associate Director for Regulatory Affairs Office of New Drugs, CDER, FDA

Strategies to Prepare for Meetings with the FDA. Kim Colangelo Associate Director for Regulatory Affairs Office of New Drugs, CDER, FDA Strategies to Prepare for Meetings with the FDA Kim Colangelo Associate Director for Regulatory Affairs Office of New Drugs, CDER, FDA Topics for Discussion Who Are We? How Do We Interact Internally? Why

More information

RESEARCH INVOLVING HUMAN SUBJECTS

RESEARCH INVOLVING HUMAN SUBJECTS RESEARCH INVOLVING HUMAN SUBJECTS GUIDELINES FOR IRBS PART A: INTRODUCTION AND CURRENT FRAMEWORK SECTION I: INTRODUCTION 1. Introduction About these Guidelines 1.1. The Bioethics Advisory Committee (BAC)

More information

Systematic Drug Repurposing: Some Successes, Caveats, and Directions

Systematic Drug Repurposing: Some Successes, Caveats, and Directions Systematic Drug Repurposing: Some Successes, Caveats, and Directions Christopher P. Austin, M.D. Director, Division of Preclinical Innovation National Center for Advancing Translational Sciences National

More information

Health Care Job Information Sheet #20. Clinical Research

Health Care Job Information Sheet #20. Clinical Research Health Care Job Information Sheet #20 Clinical Research A. Background B. Occupations 1) Clinical Research Associate (Study Monitor) 2) Clinical Research Coordinator 3) Other positions in the field C. Labour

More information

Salary Survey 2014. Domestic, International Salary Survey and Country Cost Analysis

Salary Survey 2014. Domestic, International Salary Survey and Country Cost Analysis Salary Survey 2014 Domestic, International Salary Survey and Country Cost Analysis Disclaimer: This salary guides contained herewith have been constructed to represent average salaries across a range of

More information

A Comparison of Two Commonly Used CRO Resourcing Models for SAS/ Statistical Programmers R. Mouly Satyavarapu, PharmaNet/ i3, Ann Arbor, MI

A Comparison of Two Commonly Used CRO Resourcing Models for SAS/ Statistical Programmers R. Mouly Satyavarapu, PharmaNet/ i3, Ann Arbor, MI PharmaSUG 2012 - Paper MS11 A Comparison of Two Commonly Used CRO Resourcing Models for SAS/ R. Mouly Satyavarapu, PharmaNet/ i3, Ann Arbor, MI ABSTRACT: Why do we have Contract Research Organizations

More information

Quality Assurance: Best Practices in Clinical SAS Programming. Parag Shiralkar

Quality Assurance: Best Practices in Clinical SAS Programming. Parag Shiralkar Quality Assurance: Best Practices in Clinical SAS Programming Parag Shiralkar eclinical Solutions, a Division of Eliassen Group Abstract SAS programmers working on clinical reporting projects are often

More information

Issues. Does the academe have as a goal or an obligation, the development of its discoveries for human benefit?

Issues. Does the academe have as a goal or an obligation, the development of its discoveries for human benefit? ELLEN PURÉ, Ph.D. Issues Does the academe have as a goal or an obligation, the development of its discoveries for human benefit? Can the academic review process support individual career development in

More information

Overview of CDISC Implementation at PMDA. Yuki Ando Senior Scientist for Biostatistics Pharmaceuticals and Medical Devices Agency (PMDA)

Overview of CDISC Implementation at PMDA. Yuki Ando Senior Scientist for Biostatistics Pharmaceuticals and Medical Devices Agency (PMDA) Overview of CDISC Implementation at PMDA Yuki Ando Senior Scientist for Biostatistics Pharmaceuticals and Medical Devices Agency (PMDA) CDISC 2012 Outline Introduction Update of PMDA activity CDISC implementation

More information

The Trials and Tribulations of the CRM: the DFO Experience

The Trials and Tribulations of the CRM: the DFO Experience The Trials and Tribulations of the CRM: the DFO Experience Yuko Y. Palesch, PhD Professor and Director, Division of Biostatistics and Epidemiology Department of Medicine. Medical University of South Carolina

More information

U.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade. N8B7-52 December 2010

U.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade. N8B7-52 December 2010 U.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade December 2010 Table of Contents Notes on Methodology 8 Market Introduction and Segmentation Introduction

More information

Abt Associates Inc. Abt Associates Clinical Trials Comprehensive clinical research services

Abt Associates Inc. Abt Associates Clinical Trials Comprehensive clinical research services Abt Associates Inc. Abt Associates Clinical Trials Comprehensive clinical research services Providing a wide range of clinical research services Abt Associates Clinical Trials (AACT) is dedicated to providing

More information

To know more about Pharmacovigilance and Clinical Trials Data Management

To know more about Pharmacovigilance and Clinical Trials Data Management To know more about Pharmacovigilance and Clinical Trials Data Management 1. What is Pharmacovigilance? Pharmacovigilance (PV) is the pharmacological science related to the detection, assessment, understanding

More information

Later-Stage Development: Ensuring Compliance During. for a Competitive Advantage Webinar Series

Later-Stage Development: Ensuring Compliance During. for a Competitive Advantage Webinar Series Part II: Later-Stage Development: Ensuring Compliance During Clinical i l Trials Process Driven Compliance for a Competitive Advantage Webinar Series 29 September 2010 Process Driven Compliance Webinar

More information

Clinical Data Management Overview

Clinical Data Management Overview The 2 nd Clinical Data Management Training Clinical Data Management Overview Andrew Taylor ( 安 泰 乐 ), M.S. Head of Clinical Data Management August 30, 2010 Learning Objectives Overview of Process Related

More information

A Cost Effective Way to De Risk Biomarker Clinical Trials: Early Development Considerations

A Cost Effective Way to De Risk Biomarker Clinical Trials: Early Development Considerations A Cost Effective Way to De Risk Biomarker Clinical Trials: Early Development Considerations Ce3, Inc. and Insight Genetics, Inc. Oncology Forum July 15, 2015 Agenda Introductions Definitions Regulations

More information

Join our scientific talent community

Join our scientific talent community Join our scientific talent community There has never been a better time to be a part of Janssen Research & Development. We are at the forefront of healthcare leading, evolving and transforming it into

More information

Research Investments in Large Indian Software Companies

Research Investments in Large Indian Software Companies Research Investments in Large Indian Software Companies Pankaj Jalote Professor, Department of Computer Science and Engineering Indian Institute of Technology Kanpur, India 208016 jalote@iitk.ac.in, www.cse.iitk.ac.in/users/jalote

More information

The Cell Therapy Catapult

The Cell Therapy Catapult The Cell Therapy Catapult Keith Thompson CEO January 29 2013 info@ct.catapult.org.uk Catapult is a Technology Strategy Board programme The Launch of Catapults Hauser 2 Hauser Report Creating new manufacturing

More information

Proof-of-Concept Studies and the End of Phase IIa Meeting with the FDA

Proof-of-Concept Studies and the End of Phase IIa Meeting with the FDA Medpace Discovery Series presents Proof-of-Concept Studies and the End of Phase IIa Meeting with the FDA DR. JIM WEI: Today my topic is going to be Proof-of-Concept Studies and FDA End of Phase 2a Meetings

More information

TIBCO Spotfire Helps Organon Bridge the Data Gap Between Basic Research and Clinical Trials

TIBCO Spotfire Helps Organon Bridge the Data Gap Between Basic Research and Clinical Trials TIBCO Spotfire Helps Organon Bridge the Data Gap Between Basic Research and Clinical Trials Pharmaceutical leader deploys TIBCO Spotfire enterprise analytics platform across its drug discovery organization

More information

exactly. The need for efficiency in developing effective new therapeutics has never been greater.

exactly. The need for efficiency in developing effective new therapeutics has never been greater. exactly. The need for efficiency in developing effective new therapeutics has never been greater. As demands on the global healthcare system increase and treating disease becomes more complex, the research,

More information

Patient Handbook on Stem Cell Therapies

Patient Handbook on Stem Cell Therapies Patient Handbook on Stem Cell Therapies Appendix I of the Guidelines for the Clinical Translation of Stem Cells www.isscr.org 2008, International Society for Stem Cell Research 2 Introduction We have all

More information

Operational aspects of a clinical trial

Operational aspects of a clinical trial Operational aspects of a clinical trial Carlo Tomino Pharm.D. Coordinator Pre-authorization Department Head of Research and Clinical Trial Italian Medicines Agency Mwanza (Tanzania), June 11, 2012 1 Declaration

More information

Strategic Consulting Services

Strategic Consulting Services Services 1 Leadership Team Mark Levonyak President mlevonyak@davaonc.com Mobile: 214.460.5051 Martin W. Lee, MD EVP, Clinical Trial Services mlee@davaonc.com Mobile: 952.373.1405 John Eckardt, MD Chief

More information

The Clinical Trials Process an educated patient s guide

The Clinical Trials Process an educated patient s guide The Clinical Trials Process an educated patient s guide Gwen L. Nichols, MD Site Head, Oncology Roche TCRC, Translational and Clinical Research Center New York DISCLAIMER I am an employee of Hoffmann-

More information

Waife & Associates, Inc. Change Management for Clinical Research

Waife & Associates, Inc. Change Management for Clinical Research Waife & Associates, Inc. Change Management for Clinical Research There is a light through the fog We help biopharmaceutical companies build global competitive advantage in their clinical research operations.

More information

Quality Thinking in other Industries. Dominic Parry Inspired Pharma Training. WEB www.inspiredpharma.com GMP BLOG inspiredpharmablog.

Quality Thinking in other Industries. Dominic Parry Inspired Pharma Training. WEB www.inspiredpharma.com GMP BLOG inspiredpharmablog. Quality Thinking in other Industries Dominic Parry Inspired Pharma Training WEB www.inspiredpharma.com GMP BLOG inspiredpharmablog.com Welcome The traditional focus on quality Quality in the eyes of GMP

More information

Master of Science in Biomedical Sciences

Master of Science in Biomedical Sciences Master of Science in Biomedical Sciences Faculty of Medicine Good health is our greatest treasure. Understanding the human body, healthy and diseased, is the stepping stone to finding tools to improving

More information

Job Profile Clinical Research Associate III (CRA)

Job Profile Clinical Research Associate III (CRA) PART 1 - PROFILE You are an experienced CRA with a strong background in Clinical Research who is passionate about drug development and are seeking a challenging and rewarding career in a quality focussed

More information

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2012) Sweden

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2012) Sweden The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe Sweden Question 1: What laws or regulations apply to an application for conducting a clinical trial in Sweden?

More information

How Public-Private Partnerships Benefit All Stakeholders Douglas C. Throckmorton, MD Deputy Director for Regulatory Programs, CDER, FDA

How Public-Private Partnerships Benefit All Stakeholders Douglas C. Throckmorton, MD Deputy Director for Regulatory Programs, CDER, FDA How Public-Private Partnerships Benefit All Stakeholders Douglas C. Throckmorton, MD Deputy Director for Regulatory Programs, CDER, FDA September 10, 2013 Outline Need for improved science in support of

More information

The Board reviews risks to the Company s business plan at its scheduled meetings.

The Board reviews risks to the Company s business plan at its scheduled meetings. Pharmaxis Ltd 1. Board responsibility The Pharmaxis Board is responsible for ensuring the Company establishes and maintains a risk management framework for the oversight and management of risk. The Board

More information

m 4 Biobank Alliance & m 4 Trial Service Center

m 4 Biobank Alliance & m 4 Trial Service Center m 4 Biobank Alliance & m 4 Trial Service Center Services & Consulting in (non-)clinical development www.m4.de m 4 Biobank Alliance Central Access to High Quality Human Biospecimens for R&D The m 4 Biobank

More information

GOG Foundation/Partners Program Overview 2015

GOG Foundation/Partners Program Overview 2015 GOG Foundation/Partners Program Overview 2015 Philip J. DiSaia, MD President GOG Foundation Larry J. Copeland, MD Vice President GOG Foundation GOG FOUNDATION/PARTNERS PROGRAM Basic Premise The Partners

More information

Oversight of Clinical Trials in Europe - Member State perspective. Gunnar Danielsson Senior Expert Pharmaceutical Inspector

Oversight of Clinical Trials in Europe - Member State perspective. Gunnar Danielsson Senior Expert Pharmaceutical Inspector Oversight of Clinical Trials in Europe - Member State perspective Gunnar Danielsson Senior Expert Pharmaceutical Inspector Oversight of Clinical Trials Oversight of clinical trials occur on many different

More information

Annex 7 Guidelines for the preparation of a contract research organization master file

Annex 7 Guidelines for the preparation of a contract research organization master file World Health Organization WHO Technical Report Series, No. 957, 2010 Annex 7 Guidelines for the preparation of a contract research organization master file Background 1. General information 2. Quality

More information

HEALTH ECONOMICS AND OUTCOMES RESEARCH SERVICES

HEALTH ECONOMICS AND OUTCOMES RESEARCH SERVICES HEALTH ECONOMICS AND OUTCOMES RESEARCH SERVICES Health Economics and Outcomes Research cannot operate in a silo. An optimal value proposition requires strong and robust HEOR statements. We develop the

More information

Clinical Research Associate (CRA) - A Growing Career Path in Biotechnology / Pharmaceutical Industry

Clinical Research Associate (CRA) - A Growing Career Path in Biotechnology / Pharmaceutical Industry Clinical Research Associate (CRA) - A Growing Career Path in Biotechnology / Pharmaceutical Industry By http://www.clinicalresearchassociate cra.com/studyguide/ A clinical research associate (CRA) is a

More information

The Role of Regional Medical Advisor (RMA)-Field Medical. Dr. Aju Abraham Varghese Pfizer India. Feb 22 nd 2014

The Role of Regional Medical Advisor (RMA)-Field Medical. Dr. Aju Abraham Varghese Pfizer India. Feb 22 nd 2014 The Role of Regional Medical Advisor (RMA)-Field Medical Dr. Aju Abraham Varghese Pfizer India Feb 22 nd 2014 Disclaimer The opinions expressed in this presentation are solely those of the presenter and

More information

Pharmaceutical Quality & Clinical Research Quality: The Interaction

Pharmaceutical Quality & Clinical Research Quality: The Interaction 4 th Jerusalem Conference: Quality by Design (QbD)) & Pharma Sciences, May 20-22, 2014 The Edmund Safra Campus, The Hebrew University of Jerusalem Pharmaceutical Quality & Clinical Research Quality: The

More information

Ferring Pharmaceuticals Running a virtual department through outsourcing

Ferring Pharmaceuticals Running a virtual department through outsourcing Ferring Pharmaceuticals Running a virtual department through outsourcing Silvana Cappi Running a virtual department through outsourcing the situation outsourcing strategy outsourcing models key success

More information

Jobbetegnelser for det nuværende job i branchen

Jobbetegnelser for det nuværende job i branchen Jobbetegnelser for det nuværende job i branchen Administrerende direktør (CEO) Academic, Project manage Advanced Business Analyst Advanced Business Analyst, IT&CD, IT System Management Analytical Service

More information

Part 3 Medical Officer (MO) Work Level Standards

Part 3 Medical Officer (MO) Work Level Standards Part 3 Medical Officer (MO) Work Level Standards MEDICAL OFFICER-CLASSES 1 6 GROUP STANDARD The work of positions in this group involves the application of professional medical knowledge and experience

More information

Our Team. Your strategic partner for the entire medical product lifecycle. Quality Expertise Efficiency Teamwork

Our Team. Your strategic partner for the entire medical product lifecycle. Quality Expertise Efficiency Teamwork Our Team Your strategic partner for the entire medical product lifecycle At Boston Biomedical Associates, our experienced and dedicated employees define how we work and give us a competitive advantage

More information

Guidance for Industry

Guidance for Industry Guidance for Industry End-of-Phase 2A Meetings U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) September 2009 Procedural Guidance

More information

Topic 3 RISK MANAGEMENT APPROACH for CMC SUBMISSIONS AND REVIEW. Topic Leaders Kim Huynh-Ba, Pharmalytik Lynn Gold, Camargo

Topic 3 RISK MANAGEMENT APPROACH for CMC SUBMISSIONS AND REVIEW. Topic Leaders Kim Huynh-Ba, Pharmalytik Lynn Gold, Camargo Topic 3 RISK MANAGEMENT APPROACH for CMC SUBMISSIONS AND REVIEW Topic Leaders Kim Huynh-Ba, Pharmalytik Lynn Gold, Camargo Introduction to Speakers John Duan, Clinical Pharmacology & Biopharmaceutics Reviewer,

More information

CLINICAL TRIALS SHOULD YOU PARTICIPATE? by Gwen L. Nichols, MD

CLINICAL TRIALS SHOULD YOU PARTICIPATE? by Gwen L. Nichols, MD CLINICAL TRIALS SHOULD YOU PARTICIPATE? by Gwen L. Nichols, MD Gwen L. Nichols, M.D., is currently the Oncology Site Head of the Roche Translational Clinical Research Center at Hoffman- LaRoche. In this

More information

BOOSTING THE COMMERCIAL RETURNS FROM RESEARCH

BOOSTING THE COMMERCIAL RETURNS FROM RESEARCH BOOSTING THE COMMERCIAL RETURNS FROM RESEARCH Submission in response to the Discussion Paper November 2014 Page 1 ABOUT RESEARCH AUSTRALIA is an alliance of 160 members and supporters advocating for health

More information

There are 2 types of clinical trials that are of interest to the. The Clinical Trials Network of the Society of Nuclear Medicine

There are 2 types of clinical trials that are of interest to the. The Clinical Trials Network of the Society of Nuclear Medicine The Clinical Trials Network of the Society of Nuclear Medicine Michael M. Graham, PhD, MD The Clinical Trials Network of the Society of Nuclear Medicine was formed to provide quality assurance of both

More information

Associate Group Director, Regulatory Intelligence & Policy

Associate Group Director, Regulatory Intelligence & Policy Date: 06/24/16 Associate Group Director, Regulatory Intelligence & Policy Job ID: 2974410847 Job Function Project Management Regulatory Affairs Location United States - District of Columbia Washington

More information

Fiscal Year 2013 (FY13) Prostate Cancer Research Program (PCRP) Reference Table of Award Mechanisms and Submission Requirements

Fiscal Year 2013 (FY13) Prostate Cancer Research Program (PCRP) Reference Table of Award Mechanisms and Submission Requirements Fiscal Year 2013 (FY13) Prostate Cancer Research Program (PCRP) Reference Table of Award Mechanisms and Submission Requirements PCRP AWARD MECHANISMS WITH EMPHASIS ON RESOURCES Clinical Consortium Award

More information

THE WHAT AND WHY OF REGULATORY OUTSOURCING

THE WHAT AND WHY OF REGULATORY OUTSOURCING WHITE PAPER THE WHAT AND WHY OF REGULATORY OUTSOURCING Today s evolving healthcare landscape poses unprecedented challenges to biopharmaceutical companies. Consolidation, budget cuts, restructuring, globalization

More information

Excellence in Oncology Clinical Trials

Excellence in Oncology Clinical Trials Oncology Clinical Trials We work to find a better way. We work to raise standards and deliver more. We break new ground to make progress possible. Oncology Research ICON is a global provider of outsourced

More information

Anforderungen der Life-Science Industrie an die Hochschulen. Hans Widmer Novartis Institutes for BioMedical Research

Anforderungen der Life-Science Industrie an die Hochschulen. Hans Widmer Novartis Institutes for BioMedical Research Anforderungen der Life-Science Industrie an die Hochschulen Hans Widmer Novartis Institutes for BioMedical Research There s nothing more extraordinary than a normal life 2 What does industry expect from

More information

Achieving Regulatory Success: Areas of focus for biotechnology companies. Michael J. Schlosser, PhD, DABT April 21, 2013

Achieving Regulatory Success: Areas of focus for biotechnology companies. Michael J. Schlosser, PhD, DABT April 21, 2013 Achieving Regulatory Success: Areas of focus for biotechnology companies Michael J. Schlosser, PhD, DABT April 21, 2013 Regulatory Success Outline Regulatory Initiatives Regulatory Science Pre-Regulatory

More information

Master of Science in Nutrition and Wellness Curriculum

Master of Science in Nutrition and Wellness Curriculum Master of Science in Nutrition and Wellness Curriculum The online Master of Science in Nutrition and Wellness requires 66 credits of graduate-level coursework consisting of 38 credits of foundation courses

More information

Drug Development Process

Drug Development Process Drug Development Process Original Arthur: Addie D. Anderson CRB Consulting Engineers, Inc. Overview Important milestones establishing our current system of regulations Step-by-step overview of the drug

More information

Japan PMDA and CDISC Standards. Yuki Ando Senior Scientist for Biostatistics Pharmaceuticals and Medical Devices Agency (PMDA)

Japan PMDA and CDISC Standards. Yuki Ando Senior Scientist for Biostatistics Pharmaceuticals and Medical Devices Agency (PMDA) Japan PMDA and CDISC Standards Yuki Ando Senior Scientist for Biostatistics Pharmaceuticals and Medical Devices Agency (PMDA) CDISC 2012 1 Outline New drug review process in Japan Task force for advanced

More information

Virtual Clinical Organization: The New Clinical Development Operating Model

Virtual Clinical Organization: The New Clinical Development Operating Model Cognizant 20-20 Insights Virtual Clinical Organization: The New Clinical Development Operating Model Executive Summary Clinical development executives are facing more pressure than ever to reduce costs

More information

Current Situation of Research Nurse Education and Future Perspectives in Japan

Current Situation of Research Nurse Education and Future Perspectives in Japan Current Situation of Research Nurse Education and Future Perspectives in Japan Eriko Aotani Clinical Trials Coordinating Center The Kitasato Institute 1 Who are involved in Clinical Trials? Patients. Others

More information

A Model for Centralized Monitoring & Clinical Data Management Reducing costs while ensuring compliance, risk mitigation & quality

A Model for Centralized Monitoring & Clinical Data Management Reducing costs while ensuring compliance, risk mitigation & quality A Model for Centralized Monitoring & Clinical Data Management Reducing costs while ensuring compliance, risk mitigation & quality Dr Michael J. Klein Regional Head & Vice President Quintiles Sub-Saharan

More information

Roles & Responsibilities of the Sponsor

Roles & Responsibilities of the Sponsor Roles & Responsibilities of the Sponsor Developed by Center for Cancer Research, National Cancer Institute, NIH Endorsed by the CTN SIG Leadership Group Objectives Funding for clinical research comes from

More information

QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH

QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH Martin Valania, Executive Director, Corporate QA and Compliance Introduction Pharmaceutical companies recognize the benefits of carefully managing

More information

We set things in motion and keep them moving. Metronomia Clinical Research Services

We set things in motion and keep them moving. Metronomia Clinical Research Services We set things in motion and keep them moving Metronomia Clinical Research Services Our customers love the fact that we keep up with their individual tempos. Dorothea Wessiepe, Director Biostatistics Metronomia:

More information

A clinical research organization

A clinical research organization A clinical research organization About Us State of art facility. All clinical trials carried out in accordance with ICH GCP guidelines. Quality services within stipulated time period. Team of experienced

More information

Manchester Pharmacy School. www.manchester.ac.uk/pharmacy

Manchester Pharmacy School. www.manchester.ac.uk/pharmacy Manchester Pharmacy School Postgraduate study from Continuous Professional Development (CPD), Certificate, Diploma to Masters (MSc) with flexible, modular learning. The University of Manchester has a proud

More information

Working with ICH Quality Guidelines - the Canadian Perspective

Working with ICH Quality Guidelines - the Canadian Perspective Working with ICH Quality Guidelines the Canadian Perspective Krishnan Tirunellai, Ph. D. Bureau of Pharmaceutical Sciences Therapeutic Products Directorate Health Canada December 3, 2008 Outline Introduction

More information

Biometrics: Clinical Trials and Beyond

Biometrics: Clinical Trials and Beyond Biometrics: Clinical Trials and Beyond Statistics, Programming, and Data Management in Research, Development, and Regulatory Submissions. For all, Not Just Statisticians! Keynote Presentations Sue-Jane

More information

Concepts in Pharmaceutical Development Project Management. Christopher D. Breder, MD PhD. Clinical Team Leader, Anesthetic Drugs

Concepts in Pharmaceutical Development Project Management. Christopher D. Breder, MD PhD. Clinical Team Leader, Anesthetic Drugs Concepts in Pharmaceutical Development Project Management Christopher D. Breder, MD PhD Clinical Team Leader, Anesthetic Drugs Division of Anesthesia, Analgesia, and Addiction Products Disclaimer The views

More information

Why Are Drugs So Expensive? Learning About the Drug Development Process

Why Are Drugs So Expensive? Learning About the Drug Development Process Why Are Drugs So Expensive? Page 1 of 92 Why Are Drugs So Expensive? Learning About the Drug Development Process written by: Ann Newman Seventh Street Development Group This product is for your Personal

More information

Working Model for Effective Functional Service Provider (FSP) Collaboration

Working Model for Effective Functional Service Provider (FSP) Collaboration Working Model for Effective Functional Service Provider (FSP) Collaboration Wayne Woo, Head Statistical Reporting Strategy, Novartis Vaccines August 5, 2014 Disclaimer and preface Views, opinions and thoughts

More information

BioWales 2015 Pharmaceutical Supply Chain Showcase. 04 March 2015

BioWales 2015 Pharmaceutical Supply Chain Showcase. 04 March 2015 BioWales 2015 Pharmaceutical Supply Chain Showcase 04 March 2015 SIMBEC RESEARCH 40 YEARS EXPERIENCE IN EARLY STAGE CLINICAL DRUG DEVELOPMENT BACKGROUND Over 1,200 clinical studies safely and successfully

More information

2014 Wells Fargo Healthcare Conference June 17, 2014 NYSE: Q

2014 Wells Fargo Healthcare Conference June 17, 2014 NYSE: Q 2014 Wells Fargo Healthcare Conference June 17, 2014 NYSE: Q Copyright 2013 Quintiles Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains forward-looking statements

More information

Global Contract Research Organization (CRO) Industry: Overview and Trends, 2008

Global Contract Research Organization (CRO) Industry: Overview and Trends, 2008 A Service of Indigo Research A Cipher www.indigoresearch.com Global CRO Market 2005- $15 Billion Global Contract Research Organization (CRO) Industry: Overview and Trends, 2008 Published April 2008 CRO

More information

Creative financing: Private equity in life sciences

Creative financing: Private equity in life sciences : Private equity in life sciences The Colonnade Hotel, Boston, MA October 28, 2008 Industry trends and implications 2 Setting the Stage Overall trends Aging population Emerging market opportunities - access

More information

Department/Academic Unit: Public Health Sciences Degree Program: Biostatistics Collaborative Program

Department/Academic Unit: Public Health Sciences Degree Program: Biostatistics Collaborative Program Department/Academic Unit: Public Health Sciences Degree Program: Biostatistics Collaborative Program Department of Mathematics and Statistics Degree Level Expectations, Learning Outcomes, Indicators of

More information

10 Essential Steps to Portfolio Management

10 Essential Steps to Portfolio Management 10 Essential Steps to Portfolio Management Portfolio Planning for 2013 Revised November 2012 http://epmlive.com Contents Introduction...2 Portfolio Management Overview...3 Portfolio Management Process

More information

Innovation Quality Flexibility

Innovation Quality Flexibility What a Lead Programmer Does for effective project management of programming activities under various outsourced models Innovation Quality Flexibility Agenda Understanding the Operating Model Impact Defining

More information

The Top 10 Contract Research Organizations

The Top 10 Contract Research Organizations OUTSOURCING The Top 10 Contract Research Organizations Positioning, performance and SWOT analyses Table of Contents Copyright 2009 Business Insights Ltd This Management Report is published by Business

More information

PharmD Postdoctoral Fellowship Program

PharmD Postdoctoral Fellowship Program Novartis Institutes for Biomedical Research and Massachusetts College of Pharmacy and Health Sciences, Worcester/Manchester PharmD Postdoctoral Fellowship Program Introduction Fellowship training in the

More information

Overview of Drug Development: the Regulatory Process

Overview of Drug Development: the Regulatory Process Overview of Drug Development: the Regulatory Process Roger D. Nolan, PhD Director, Project Operations Calvert Research Institute November, 2006 Adapted from course taught by Cato Research Background: Roger

More information

Programme du parcours Clinical Epidemiology 2014-2015. UMR 1. Methods in therapeutic evaluation A Dechartres/A Flahault

Programme du parcours Clinical Epidemiology 2014-2015. UMR 1. Methods in therapeutic evaluation A Dechartres/A Flahault Programme du parcours Clinical Epidemiology 2014-2015 UR 1. ethods in therapeutic evaluation A /A Date cours Horaires 15/10/2014 14-17h General principal of therapeutic evaluation (1) 22/10/2014 14-17h

More information